Ariel Investments released its “Ariel Fund” third-quarter 2025 investor letter, noting U.S equities rallied due to factors like the Federal Reserve’s rate cut. Ariel Fund returned +12.39% in the quarter, surpassing the Russell 2500 Value Index but lagging behind the Russell 2000 Value Index.

Prestige Consumer Healthcare Inc. (NYSE:PBH) was highlighted in the letter, with a one-month return of -0.60% and shares losing 14.31% over 52 weeks. On October 23, 2025, PBH stock closed at $62.59 per share with a market capitalization of $3.08 billion.

Ariel Fund stated that Prestige Consumer Healthcare Inc. (NYSE:PBH) declined following mixed earnings results and a revision to full-year guidance. Sales were impacted by limited inventory in the eye care segment but an acquisition is expected to strengthen supply. PBH reaffirmed its free cash flow outlook and strategic plans.

Prestige Consumer Healthcare Inc. (NYSE:PBH) is not among the 30 most popular stocks among hedge funds. In the fiscal first quarter of 2026, PBH reported revenue of $249.5 million compared to $267.1 million in the prior year’s quarter. While PBH has investment potential, certain AI stocks may offer greater upside potential and less downside risk.

Read more at Yahoo Finance: Prestige Consumer Healthcare (PBH) Slipped on Mixed Results and Reduced Guidance